U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888843) titled 'Study to Evaluate the Use of Capecitabine in Monotherapy and in Combination with Oxaliplatin in Elderly Patients As Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer.' on March 06.
Brief Summary: All patients with locally advanced colorectal cancer after radical surgical intervention who have not previously received systemic antitumor treatment will be randomized into two groups receiving fluoropyrimidines in mono-regimen and in combination with oxaliplatin.
Main objectives:
* to compare the 3-year disease-free survival and 5-year overall survival rates in the two groups.
* to identify, through a comprehensive geriatr...